Chitra Mandal

Chitra Mandal is a chemical biologist in the field of biomolecules and their applications in health and diseases. She is currently the Director of CSIR - Indian Institute of Chemical biology in Kolkata, India.

Chitra Mandal
NationalityIndian
Alma materUniversity of Pennsylvania IISC Bangalore
AwardsJC Bose National Fellowship
Scientific career
InstitutionsCSIR Indian Institute of Chemical Research

Education and career

Mandal completed her PhD early on in her career from Indian Institute of Science, Bangalore, in the area of bio-organic chemistry. She went on to do post doctoral research at University of Pennsylvania in Philadelphia. Returning to India, she became a scientist at CSIR, until she went on to head its Innovation Complex in Kolkata, and then its Director. Her research area is mainly the glycolsylation of biomolecules and their potential application in disease management, cancer and tumor immunology.[1] The lab is also investigating low cost healthcare solutions using medicinal plants indigenous to India, for example, the identification of a non-toxic herbal molecule in cancer cell treatments. There has been some controversy regarding duplicated images in some of her papers.[2]

Retracted scientific papers

On 3 February 2020 a 2012 paper, PLoS ONE 7(3): e34277, where Chitra Mandal was senior and corresponding author, was retracted by the editors. [3] On 24 October 2019 a 2012 paper, PLoS One. 2012;7(7):e42361, where Chitra Mandal is senior and corresponding author, was retracted by the editors. [4] In 2009 another paper, this time in the journal Infection and Immunity, was retracted.</ref>RETRACTED: Sialic acids, important constituents and selective recognition factors of Pseudomonas aeruginosa, an opportunistic pathogen</ref>

References
  1. "Welcome to CSIR - Indian Institute of Chemical Biology". iicb.res.in. Archived from the original on 5 June 2017. Retrieved 4 March 2017.
  2. Ravindranath, Prasad (6 June 2019). "19 papers of Chitra Mandal from CSIR-Indian Institute of Chemical Biology have duplicated images".
  3. Editors, The PLOS ONE (3 February 2020). "Retraction: Bak Compensated for Bax in p53-null Cells to Release Cytochrome c for the Initiation of Mitochondrial Signaling during Withanolide D-Induced Apoptosis". PLOS ONE. 15 (2): e0228839. doi:10.1371/journal.pone.0228839. PMC 6996816. PMID 32012207 – via PLoS Journals.CS1 maint: extra text: authors list (link)
  4. Editors, The PLOS ONE (24 October 2019). "Retraction: Sialoglycosylation of RBC in Visceral Leishmaniasis Leads to Enhanced Oxidative Stress, Calpain-Induced Fragmentation of Spectrin and Hemolysis". PLOS ONE. 14 (10): e0224539. doi:10.1371/journal.pone.0224539. PMC 6812758. PMID 31648292 – via PLoS Journals.CS1 maint: extra text: authors list (link)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.